Enseval Putra Megatrading Tbk (EPMT) - Total Assets

Latest as of September 2025: Rp12.23 Trillion IDR ≈ $716.47 Million USD

Based on the latest financial reports, Enseval Putra Megatrading Tbk (EPMT) holds total assets worth Rp12.23 Trillion IDR (≈ $716.47 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Enseval Putra Megatrading Tbk net assets for net asset value and shareholders' equity analysis.

Enseval Putra Megatrading Tbk - Total Assets Trend (2000–2024)

This chart illustrates how Enseval Putra Megatrading Tbk's total assets have evolved over time, based on quarterly financial data.

Enseval Putra Megatrading Tbk - Asset Composition Analysis

Current Asset Composition (December 2024)

Enseval Putra Megatrading Tbk's total assets of Rp12.23 Trillion consist of 83.7% current assets and 16.3% non-current assets.

Asset Category Amount (IDR) % of Total Assets
Cash & Equivalents Rp0.00 6.0%
Accounts Receivable Rp4.44 Trillion 38.6%
Inventory Rp3.94 Trillion 34.3%
Property, Plant & Equipment Rp1.58 Trillion 13.8%
Intangible Assets Rp10.23 Billion 0.1%
Goodwill Rp0.00 0.0%

Asset Composition Trend (2000–2024)

This chart illustrates how Enseval Putra Megatrading Tbk's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Enseval Putra Megatrading Tbk (EPMT) total market value.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Enseval Putra Megatrading Tbk's current assets represent 83.7% of total assets in 2024, an increase from 0.0% in 2000.
  • Cash Position: Cash and equivalents constituted 6.0% of total assets in 2024, up from 2.8% in 2000.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2000.
  • Asset Diversification: The largest asset category is accounts receivable at 38.6% of total assets.

Enseval Putra Megatrading Tbk Competitors by Total Assets

Key competitors of Enseval Putra Megatrading Tbk based on total assets are shown below.

Company Country Total Assets
Guangxi Liuzhou Pharm Co Ltd
SHG:603368
China CN¥21.18 Billion
Sigma Healthcare Ltd
AU:SIG
Australia AU$8.74 Billion
Ebos Group Ltd
AU:EBO
Australia AU$7.84 Billion
Paragon Care Ltd
AU:PGC
Australia AU$1.31 Billion
Mayne Pharma Group Ltd
AU:MYX
Australia AU$1.01 Billion
Cyclopharm Ltd
AU:CYC
Australia AU$55.91 Million
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
Brazil R$5.64 Billion
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
China CN¥233.15 Billion

Enseval Putra Megatrading Tbk - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 2.36 2.56 2.98
Quick Ratio 1.46 1.53 2.06
Cash Ratio 0.00 0.00 0.00
Working Capital Rp5.97 Trillion Rp5.82 Trillion Rp5.01 Trillion

Enseval Putra Megatrading Tbk - Advanced Valuation Insights

This section examines the relationship between Enseval Putra Megatrading Tbk's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.82
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) 4.9%
Total Assets Rp11.49 Trillion
Market Capitalization $374.57 Million USD

Valuation Analysis

Below Book Valuation: The market values Enseval Putra Megatrading Tbk's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Enseval Putra Megatrading Tbk's assets grew by 4.9% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Enseval Putra Megatrading Tbk (2000–2024)

The table below shows the annual total assets of Enseval Putra Megatrading Tbk from 2000 to 2024.

Year Total Assets Change
2024-12-31 Rp11.49 Trillion
≈ $673.12 Million
+4.85%
2023-12-31 Rp10.96 Trillion
≈ $641.97 Million
+5.32%
2022-12-31 Rp10.40 Trillion
≈ $609.54 Million
+6.91%
2021-12-31 Rp9.73 Trillion
≈ $570.13 Million
+5.63%
2020-12-31 Rp9.21 Trillion
≈ $539.77 Million
+5.82%
2019-12-31 Rp8.70 Trillion
≈ $510.08 Million
+4.59%
2018-12-31 Rp8.32 Trillion
≈ $487.69 Million
+12.08%
2017-12-31 Rp7.43 Trillion
≈ $435.12 Million
+4.78%
2016-12-31 Rp7.09 Trillion
≈ $415.29 Million
+5.03%
2015-12-31 Rp6.75 Trillion
≈ $395.40 Million
+9.00%
2014-12-31 Rp6.19 Trillion
≈ $362.75 Million
+11.99%
2013-12-31 Rp5.53 Trillion
≈ $323.92 Million
+11.64%
2012-12-31 Rp4.95 Trillion
≈ $290.15 Million
+13.29%
2011-12-31 Rp4.37 Trillion
≈ $256.11 Million
+34.29%
2010-12-31 Rp3.25 Trillion
≈ $190.72 Million
+8.99%
2009-12-31 Rp2.99 Trillion
≈ $174.98 Million
+18.81%
2008-12-31 Rp2.51 Trillion
≈ $147.27 Million
+20.00%
2007-12-31 Rp2.09 Trillion
≈ $122.73 Million
+15.41%
2006-12-31 Rp1.81 Trillion
≈ $106.34 Million
-2.36%
2005-12-31 Rp1.86 Trillion
≈ $108.91 Million
+12.38%
2004-12-31 Rp1.65 Trillion
≈ $96.92 Million
+25.16%
2003-12-31 Rp1.32 Trillion
≈ $77.43 Million
+20.31%
2002-12-31 Rp1.10 Trillion
≈ $64.36 Million
+22.51%
2001-12-31 Rp896.59 Billion
≈ $52.54 Million
+9.39%
2000-12-31 Rp819.62 Billion
≈ $48.03 Million
--

About Enseval Putra Megatrading Tbk

JK:EPMT Indonesia Medical Distribution
Market Cap
$374.57 Million
Rp6.39 Trillion IDR
Market Cap Rank
#13988 Global
#169 in Indonesia
Share Price
Rp2360.00
Change (1 day)
-0.42%
52-Week Range
Rp2200.00 - Rp2570.00
All Time High
Rp2784.05
About

PT Enseval Putera Megatrading Tbk., together with its subsidiaries, engages in the distribution and supply of pharmaceutical products, consumer products, medical equipment, cosmetics, and other products in Indonesia. The company operates through Pharmaceutical, Consumer Products, and Others segments. It also trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical… Read more